JDRF Blog

Latest in Beta cell replacement

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • JDRF Beta Cell Replacement Consortium: Partnerships and Paradigm Shifts

    November 27, 2019

    Last week’s JDRF Beta Cell Replacement Consortium enabled 57 researchers the chance to collaborate in ways that help move research forward more...

  • Production of Insulin in People with Type 1 Diabetes

    November 25, 2019

    Sernova, a clinical-stage regenerative medicine company, has shown in its JDRF-funded clinical trial that its cell replacement therapy, the Cell Pouch System™,...

  • Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

    September 4, 2019

    In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

  • JDRF Hosts 3D Bioprinting Workshop for Type 1 Diabetes

    August 12, 2019

    “The final results should be more mature ‘cellular products’ for beta cell replacement as a functional cure for T1D.” Francesca Spagnoli, Ph.D.,...

  • Sanjoy Dutta, Ph.D.: The Beginning of the ADA Scientific Sessions

    June 8, 2019

    The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights the beta cell replacement therapies....

  • JDRF Beta Cell Replacement Consortium: Sharing Data and Resources, Saving Time and Money

    June 5, 2019

    The JDRF Spring Beta Cell Replacement Consortium meeting, held recently in NYC, allowed 55 researchers from a diversity of destinations and expertise...